Skip to main content
TipRanks
Go Ultimate75% OFF

Protagonist Therapeutics (PTGX) Ratios

777 Followers

Protagonist Therapeutics Ratios

PTGX's free cash flow for Q3 2026 was $-23.46M. For the 2026 fiscal year, PTGX's free cash flow was decreased by $-237.00K and operating cash flow was $-23.22M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio12.7112.4816.717.807.74
Quick Ratio12.7112.4816.717.807.74
Cash Ratio2.832.058.784.032.81
Solvency Ratio-2.343.98-3.56-3.84-2.58
Operating Cash Flow Ratio1.273.89-3.30-3.47-2.45
Short-Term Operating Cash Flow Coverage25.26361.080.000.000.00
Net Current Asset Value$ 522.39M$ 522.21M$ 334.30M$ 210.76M$ 293.06M
Leverage Ratios
Debt-to-Assets Ratio0.020.010.000.010.02
Debt-to-Equity Ratio0.020.020.000.020.02
Debt-to-Capital Ratio0.020.020.000.020.02
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.091.101.061.151.16
Debt Service Coverage Ratio-56.45541.200.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.160.180.020.070.13
Net Debt to EBITDA0.92-0.312.050.950.96
Profitability Margins
Gross Profit Margin97.34%100.00%100.00%100.00%100.00%
EBIT Margin-281.01%64.32%-156.09%-494.24%-460.01%
EBITDA Margin-278.23%64.51%-150.57%-481.56%-449.87%
Operating Profit Margin-343.63%58.20%-156.09%-494.24%-460.01%
Pretax Profit Margin-281.01%64.32%-131.59%-479.26%-458.94%
Net Profit Margin-282.83%63.34%-131.59%-479.26%-458.94%
Continuous Operations Profit Margin-282.83%63.34%-131.59%-479.26%-458.94%
Net Income Per EBT100.65%98.49%100.00%100.00%100.00%
EBT Per EBIT81.78%110.51%84.31%96.97%99.77%
Return on Assets (ROA)-19.43%36.95%-22.06%-51.38%-36.11%
Return on Equity (ROE)-21.17%40.75%-23.45%-59.09%-41.85%
Return on Capital Employed (ROCE)-25.32%36.26%-27.82%-60.61%-41.44%
Return on Invested Capital (ROIC)-25.23%35.69%-27.72%-59.92%-41.14%
Return on Tangible Assets-19.43%36.95%-22.06%-51.38%-36.11%
Earnings Yield-2.34%11.58%-6.07%-23.81%-7.92%
Efficiency Ratios
Receivables Turnover10.232.585.81511.175.13
Payables Turnover0.230.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover3.9434.4627.925.754.06
Asset Turnover0.070.580.170.110.08
Working Capital Turnover Ratio0.090.990.220.100.10
Cash Conversion Cycle-1555.14141.5662.850.7171.15
Days of Sales Outstanding35.66141.5662.850.7171.15
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding1590.800.000.000.000.00
Operating Cycle35.66141.5662.850.7171.15
Cash Flow Ratios
Operating Cash Flow Per Share0.912.99-1.24-2.20-2.33
Free Cash Flow Per Share0.882.97-1.25-2.22-2.35
Dividend Paid and CapEx Coverage Ratio36.27135.91-115.33-136.02-97.97
Capital Expenditure Coverage Ratio36.27135.91-115.33-136.02-97.97
Operating Cash Flow Coverage Ratio5.5916.95-61.56-29.58-18.41
Operating Cash Flow to Sales Ratio1.250.42-1.17-4.07-3.94
Free Cash Flow Yield1.01%7.69%-5.44%-20.36%-6.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-42.608.64-16.49-4.20-12.62
Price-to-Sales (P/S) Ratio120.665.4721.6920.1357.91
Price-to-Book (P/B) Ratio9.033.523.872.485.28
Price-to-Free Cash Flow (P/FCF) Ratio99.0113.00-18.37-4.91-14.54
Price-to-Operating Cash Flow Ratio96.2812.91-18.53-4.95-14.69
Price-to-Earnings Growth (PEG) Ratio0.29-0.020.370.86-0.33
Enterprise Value Multiple-42.458.17-12.35-3.23-11.92
Enterprise Value5.43B2.29B1.12B412.96M1.47B
EV to EBITDA-42.458.17-12.35-3.23-11.92
EV to Sales118.105.2718.6015.5453.60
EV to Free Cash Flow96.9012.53-15.75-3.79-13.46
EV to Operating Cash Flow94.2312.44-15.89-3.82-13.60
Tangible Book Value Per Share9.6710.975.934.406.48
Shareholders’ Equity Per Share9.6710.975.934.406.48
Tax and Other Ratios
Effective Tax Rate-0.010.020.000.000.00
Revenue Per Share0.727.061.060.540.59
Net Income Per Share-2.054.47-1.39-2.60-2.71
Tax Burden1.010.981.001.001.00
Interest Burden1.001.000.840.971.00
Research & Development to Revenue3.460.322.004.754.61
SG&A to Revenue0.970.100.561.190.99
Stock-Based Compensation to Revenue1.000.090.490.910.60
Income Quality-0.440.670.890.850.86

Currency in USD